These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 38744865)
1. Targeting tumor suppressor p53 for organ fibrosis therapy. Bao YN; Yang Q; Shen XL; Yu WK; Zhou L; Zhu QR; Shan QY; Wang ZC; Cao G Cell Death Dis; 2024 May; 15(5):336. PubMed ID: 38744865 [TBL] [Abstract][Full Text] [Related]
2. Snai1-induced partial epithelial-mesenchymal transition orchestrates p53-p21-mediated G2/M arrest in the progression of renal fibrosis via NF-κB-mediated inflammation. Qi R; Wang J; Jiang Y; Qiu Y; Xu M; Rong R; Zhu T Cell Death Dis; 2021 Jan; 12(1):44. PubMed ID: 33414422 [TBL] [Abstract][Full Text] [Related]
3. Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells. Shaikh SB; Prabhu A; Bhandary YP Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1441-1452. PubMed ID: 32990549 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of a potential therapeutic target NPAS2, regulated by p53, alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via suppressing HES1. Chen Y; He Z; Zhao B; Zheng R Cell Signal; 2023 Sep; 109():110795. PubMed ID: 37406788 [TBL] [Abstract][Full Text] [Related]
5. p53 and Myofibroblast Apoptosis in Organ Fibrosis. McElhinney K; Irnaten M; O'Brien C Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047710 [TBL] [Abstract][Full Text] [Related]
6. Chk2 Modulates Bmi1-Deficiency-Induced Renal Aging and Fibrosis via Oxidative Stress, DNA Damage, and p53/TGFβ1-Induced Epithelial-Mesenchymal Transition. Lu J; Sun W; Liu B; Zhang J; Wang R; Goltzman D; Miao D Int J Biol Sci; 2024; 20(6):2008-2026. PubMed ID: 38617548 [TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT. Lin S; Yu L; Ni Y; He L; Weng X; Lu X; Zhang C Diabetes Metab J; 2020 Feb; 44(1):158-172. PubMed ID: 31701691 [TBL] [Abstract][Full Text] [Related]
9. Senescence and aging: the critical roles of p53. Rufini A; Tucci P; Celardo I; Melino G Oncogene; 2013 Oct; 32(43):5129-43. PubMed ID: 23416979 [TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT. Srivastava SP; Koya D; Kanasaki K Biomed Res Int; 2013; 2013():125469. PubMed ID: 24089659 [TBL] [Abstract][Full Text] [Related]
11. Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness. Olivos DJ; Mayo LD Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898034 [TBL] [Abstract][Full Text] [Related]
12. F-box protein FBXO31 modulates apoptosis and epithelial-mesenchymal transition of cervical cancer via inactivation of the PI3K/AKT-mediated MDM2/p53 axis. Liu K; Xue B; Bai G; Zhang W Life Sci; 2020 Oct; 259():118277. PubMed ID: 32800832 [TBL] [Abstract][Full Text] [Related]